Differences in hazard ratios for CVD-related death were minor between those with and without diabetes, with a slight trend towards lower hazard among those with the disease in the high statin group, and the reverse in the no statin group.
← all excerpts
Risk of mortality and recurrent cardiovascular events in patients with acute coronary syndromes on high intensity statin treatment.
1
—
—